Go Back

Company or ticker...

Relay Therapeutics

Relay uses structural biology and computation to design precision cancer medicines.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

RLAY

4.0B

290.7

n/a

122.28%

Key Facts

M. Cap

PS

PE

YTD

4.0B

290.7

n/a

122.28%

10MA

20MA

50MA

200MA

$RLAY

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now